CD8A and diffuse large B-cell lymphoma: The in vitro and in vivo data from Zheng et al. [300] showed that miR-155 overexpression enhances PD-L1 expression, reduces peripheral blood immune cells, induces CD8+ T-cell apoptosis and dysfunction via AKT/ERK dephosphorylation, and decreases the survival of DLBCL patients.